Bartlett, J.G., "Protease inhibitors for HIV infection." Annals of
Internal Medicine. 1996; 124:1086-1088. 

C. Carpenter a.o.: Antiretroviral therapy for HIV infection in 1996.
JAMA 276 (1996), 146-154.

A. Collier a.o.: Treatment for human immunodeficiency virus infection with
saquinivir, zidovudine, and zalcitabine.
New England J. Med. 334 (1996), 1011-1017.

R. Coombs a.o.: Association of plasma human immunodeficiency virus type-1
RNA level with risk of clinical progression in patients with advanced
infection.J. Inf. Diseases ... (ca. 1997), ...

S. Danner a.o.: A short-term study of the safety, pharmacokinetics, and
efficacy of ritonavir, an inhibitor of HIV-1 protease.
New England J. Med. 333 (1995), 1528-1533.

C. Ezzell: Emergence of the protease inhibitors - a better class of
Aids drugs? J. NIH Res. 8 (1996), 41-...

R. Goldschmidt/A. Moy: Antiretroviral drug treatment for HIV/AIDS.
Am. Family Phys. 54/2 (1996), 574-580.

R. Gulick a.o.: Potent and sustained antiretroviral activity of indinavir
(IDV) in combination with zidovudine (ZDV) and lamivudine (3TC).
In Program and Abstracts of the 3rd Conf. Retroviruses and Opportunistic
Infections, 28 January - 1 February 1996. Abstract LB 7.

D. Havlir/D. Richman: Viral dynamics of HIV: implications for drug
development and therapeutic strategies.
Ann. Internal Med. 124 (1996), 984-994.

H. Jacobsen a.o.: In vivo resistance to an HIV-1 proteinase inhibitor:
mutations, kinetics and frequencies.
J. Inf. Diseases 173 (1996), 1379-1387.

9391 Martin Markowitz: Protease inhibitors. Internet 1996.

J. Mellors a.o.: Quantitation of HIV-1 in plasma predicts outcome after
seroconversion. Ann. Internal Med. 122 (1995), 573-579.

J. Mellors a.o.: Prognosis of HIV-1 infection predicted by the quantity of
virus in plasma. Science 272 (1996), 1167-1170.

W. O'Brien/P. Hartigan/D. Martin/J. Esinhart: Changes in plasma HIV-1 RNA and
CD4+ lymphocyte count relative to treatment and progression to AIDS.
New England J. Med. 334 (1996), 426-431.

M. Saag a.o.: HIV viral load markers in clinical practice: recommendations of
an International AIDS Society-USA Expert Panel.
Nature Medicine 2 (1996), 625-629.